4.8 Article

Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progression

Publisher

NATL ACAD SCIENCES
DOI: 10.1073/pnas.152321699

Keywords

-

Funding

  1. NCI NIH HHS [U01 CA084301, CA84301-04] Funding Source: Medline
  2. NIEHS NIH HHS [ES11040, U01 ES011040] Funding Source: Medline
  3. NIGMS NIH HHS [R01 GM050006, GM50006] Funding Source: Medline

Ask authors/readers for more resources

Flap endonuclease (Fen1) is required for DNA replication and repair, and defects in the gene encoding Fen1 cause increased accumulation of mutations and genome rearrangements. Because mutations in some genes involved in these processes cause cancer predisposition, we investigated the possibility that Fen1 may function in tumorigenesis of the gastrointestinal tract. Using gene knockout approaches, we introduced a null mutation into murine Fen1. Mice homozygous for the Fen1 mutation were not obtained, suggesting absence of Fen1 expression leads to embryonic lethality. Most Fen1 heterozygous animals appear normal. However, when combined with a mutation in the adenomatous polyposis coli (Apc) gene, double heterozygous animals have increased numbers of adenocarcinomas and decreased survival. The tumors from these mice show microsatellite instability. Because one copy of the Fen1 gene remained intact in tumors, Fen1 haploinsufficiency appears to lead to rapid progression of cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available